Domů › Metastatický karcinom › Colorado › Aurora
Klinické studie Metastatický karcinom v Aurora, CO
25 studií pro Metastatický karcinom hledá účastníky v lokalitách v Aurora a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- UCHealth University of Colorado Hospital, Aurora
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Probíhá náborFáze 1
- University of Colorado Anschutz Medical Campus, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Probíhá náborFáze 3
- Research Site, Aurora
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Probíhá náborFáze 1/2
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Probíhá náborFáze 1/2
- Rocky Mountain Cancer Centers,LLP, Aurora
- Clinical and Translational Research Center(CTRC), Aurora
- University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
- a dalších 2
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- University of Colorado Health Hospital, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- University of Colorado, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado, Aurora
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Probíhá náborFáze 1/2
- Crinetics Study Site, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- University of Colorado - Aurora Cancer Center, Aurora
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Probíhá náborFáze 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Probíhá náborFáze 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Probíhá náborFáze 1
- Children's Hospital Colorado, Aurora
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Probíhá náborFáze 3
- University of Colorado Cancer Center, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
Probíhá náborFáze 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
Probíhá náborFáze 1
- University of Colorado School of Medicine, Aurora
Studie Metastatický karcinom v jiných městech
- Houston, TX104 studií
- New York City, NY93 studií
- Nashville, TN70 studií
- Boston, MA63 studií
- Los Angeles, CA57 studií
- St. Louis, MO54 studií
- Arlington, VA53 studií
- Philadelphia, PA46 studií
- Chicago, IL45 studií
- San Antonio, TX44 studií
- Washington, DC43 studií
- Dallas, TX42 studií
Další studie v Aurora
- Rakovina (všechny typy)35 studií
- Kolorektální karcinom32 studií
- Nemalobuněčný plicní karcinom31 studií
- Rakovina prsu28 studií
- Rakovina vaječníků25 studií
- Diabetes mellitus 1. typu23 studií
- Obesity22 studií
- Rakovina prostaty19 studií
- Rakovina plic19 studií
- Srdeční selhání18 studií
- Melanom18 studií
- Akutní myeloidní leukemie16 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.